Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Runx1 and CDK inhibitors help keep hair follicle stem cells inactive, affecting their future roles.

Topical IKKα inhibitors may help prevent CCS tumours.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Gefitinib therapy can cause unusual hair growth on the nose.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Drugs that block GSK-3 show promise for treating various diseases.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

QLT0267 stops hair follicle cell growth and movement.

NM2 and RLC phosphorylation are essential for normal inner ear hair cell function.

EGCG may help regrow hair by inhibiting a specific enzyme.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.